 | L5Q | Name: | 5-methyl-~{N}-[2,2,2-tris(fluoranyl)ethyl]-1,2-oxazole-3-carboxamide | Formula: | C7 H7 F3 N2 O2 | SMILES: | Cc1onc(c1)C(=O)NCC(F)(F)F | InChi: | InChI=1S/C7H7F3N2O2/c1-4-2-5(12-14-4)6(13)11-3-7(8,9)10/h2H,3H2,1H3,(H,11,13) | Definition date: | 2019-07-23 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 5-methyl-~{N}-[2,2,2-tris(fluoranyl)ethyl]-1,2-oxazole-3-carboxamide |
|
 | L5W | Name: | ~{N}-oxidanylbicyclo[2.2.1]heptane-1-carboxamide | Formula: | C8 H13 N O2 | SMILES: | ONC(=O)C12CCC(CC1)C2 | InChi: | InChI=1S/C8H13NO2/c10-7(9-11)8-3-1-6(5-8)2-4-8/h6,11H,1-5H2,(H,9,10)/t6-,8- | Definition date: | 2019-07-23 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-oxidanylbicyclo[2.2.1]heptane-1-carboxamide |
|
 | L7H | Name: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-7-methoxy-2-methyl-6-[(3~{S})-oxolan-3-yl]oxy-quinazolin-4-amine | Formula: | C23 H25 F3 N4 O3 | SMILES: | COc1cc2nc(C)nc(N[CH](C)c3cc(N)cc(c3)C(F)(F)F)c2cc1O[CH]4CCOC4 | InChi: | InChI=1S/C23H25F3N4O3/c1-12(14-6-15(23(24,25)26)8-16(27)7-14)28-22-18-9-21(33-17-4-5-32-11-17)20(31-3)10-19(18)29-13(2)30-22/h6-10,12,17H,4-5,11,27H2,1-3H3,(H,28,29,30)/t12-,17+/m1/s1 | Definition date: | 2019-07-24 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-7-methoxy-2-methyl-6-[(3~{S})-oxolan-3-yl]oxy-quinazolin-4-amine |
|
 | L7K | Name: | [(~{R})-cyclohexyl-[1-(2-phenylethyl)-1,2,3,4-tetrazol-5-yl]methyl]diazane | Formula: | C16 H24 N6 | SMILES: | NN[CH](C1CCCCC1)c2nnnn2CCc3ccccc3 | InChi: | InChI=1S/C16H24N6/c17-18-15(14-9-5-2-6-10-14)16-19-20-21-22(16)12-11-13-7-3-1-4-8-13/h1,3-4,7-8,14-15,18H,2,5-6,9-12,17H2/t15-/m1/s1 | Definition date: | 2019-07-25 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | [(~{R})-cyclohexyl-[1-(2-phenylethyl)-1,2,3,4-tetrazol-5-yl]methyl]diazane |
|
 | L9B | Name: | 4-(4-oxidanylbutyl)benzenesulfonamide | Formula: | C10 H15 N O3 S | SMILES: | N[S](=O)(=O)c1ccc(CCCCO)cc1 | InChi: | InChI=1S/C10H15NO3S/c11-15(13,14)10-6-4-9(5-7-10)3-1-2-8-12/h4-7,12H,1-3,8H2,(H2,11,13,14) | Definition date: | 2019-07-30 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 4-(4-oxidanylbutyl)benzenesulfonamide |
|
 | 88B | Name: | 4-diazanyl-4-oxidanylidene-butanoic acid | Formula: | C4 H8 N2 O3 | SMILES: | NNC(=O)CCC(O)=O | InChi: | InChI=1S/C4H8N2O3/c5-6-3(7)1-2-4(8)9/h1-2,5H2,(H,6,7)(H,8,9) | Definition date: | 2019-07-25 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 4-diazanyl-4-oxidanylidene-butanoic acid |
|
 | LBK | Name: | 6,7-dimethoxy-~{N}-[(1~{R})-1-phenylethyl]quinazolin-4-amine | Formula: | C18 H19 N3 O2 | SMILES: | COc1cc2ncnc(N[CH](C)c3ccccc3)c2cc1OC | InChi: | InChI=1S/C18H19N3O2/c1-12(13-7-5-4-6-8-13)21-18-14-9-16(22-2)17(23-3)10-15(14)19-11-20-18/h4-12H,1-3H3,(H,19,20,21)/t12-/m1/s1 | Definition date: | 2019-08-02 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 6,7-dimethoxy-~{N}-[(1~{R})-1-phenylethyl]quinazolin-4-amine |
|
 | LBQ | Name: | 4-(furan-2-ylmethylamino)benzenesulfonamide | Formula: | C11 H12 N2 O3 S | SMILES: | N[S](=O)(=O)c1ccc(NCc2occc2)cc1 | InChi: | InChI=1S/C11H12N2O3S/c12-17(14,15)11-5-3-9(4-6-11)13-8-10-2-1-7-16-10/h1-7,13H,8H2,(H2,12,14,15) | Definition date: | 2019-08-02 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 4-(furan-2-ylmethylamino)benzenesulfonamide |
|
 | LC8 | Name: | 4-(furan-2-ylmethylamino)-3-nitro-benzenesulfonamide | Formula: | C11 H11 N3 O5 S | SMILES: | N[S](=O)(=O)c1ccc(NCc2occc2)c(c1)[N+]([O-])=O | InChi: | InChI=1S/C11H11N3O5S/c12-20(17,18)9-3-4-10(11(6-9)14(15)16)13-7-8-2-1-5-19-8/h1-6,13H,7H2,(H2,12,17,18) | Definition date: | 2019-08-02 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 4-(furan-2-ylmethylamino)-3-nitro-benzenesulfonamide |
|
 | LDK | Name: | (2~{S})-2-[[(2~{S})-1,5-bis(oxidanyl)-1,5-bis(oxidanylidene)pentan-2-yl]sulfamoylamino]pentanedioic acid | Formula: | C10 H16 N2 O10 S | SMILES: | OC(=O)CC[CH](N[S](=O)(=O)N[CH](CCC(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C10H16N2O10S/c13-7(14)3-1-5(9(17)18)11-23(21,22)12-6(10(19)20)2-4-8(15)16/h5-6,11-12H,1-4H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)/t5-,6-/m0/s1 | Definition date: | 2019-08-05 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | (2~{S})-2-[[(2~{S})-1,5-bis(oxidanyl)-1,5-bis(oxidanylidene)pentan-2-yl]sulfamoylamino]pentanedioic acid |
|
 | LDQ | Name: | Hosieine | Formula: | C15 H20 N2 O | SMILES: | C[CH]1C[CH]2[CH]3CN4C(=O)C=CC=C4[CH](CN2C)[CH]13 | InChi: | InChI=1S/C15H20N2O/c1-9-6-13-11-8-17-12(4-3-5-14(17)18)10(15(9)11)7-16(13)2/h3-5,9-11,13,15H,6-8H2,1-2H3/t9-,10-,11-,13-,15-/m1/s1 | Definition date: | 2019-08-05 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 |
|
 | LDW | Name: | 5-(4-fluoranylphenoxy)pyridin-2-amine | Formula: | C11 H9 F N2 O | SMILES: | Nc1ccc(Oc2ccc(F)cc2)cn1 | InChi: | InChI=1S/C11H9FN2O/c12-8-1-3-9(4-2-8)15-10-5-6-11(13)14-7-10/h1-7H,(H2,13,14) | Definition date: | 2019-08-08 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 5-(4-fluoranylphenoxy)pyridin-2-amine |
|
 | LEQ | Name: | 5-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-ylcarbonyl)-1-methyl-pyridin-2-one | Formula: | C14 H14 N2 O2 S | SMILES: | CN1C=C(C=CC1=O)C(=O)N2CCc3sccc3C2 | InChi: | InChI=1S/C14H14N2O2S/c1-15-8-11(2-3-13(15)17)14(18)16-6-4-12-10(9-16)5-7-19-12/h2-3,5,7-8H,4,6,9H2,1H3 | Definition date: | 2019-08-09 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 5-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-ylcarbonyl)-1-methyl-pyridin-2-one |
|
 | LEZ | Name: | ~{N}-[(3-chlorophenyl)methyl]-1-(1~{H}-indol-3-ylmethyl)piperidin-4-amine | Formula: | C21 H24 Cl N3 | SMILES: | Clc1cccc(CNC2CCN(CC2)Cc3c[nH]c4ccccc34)c1 | InChi: | InChI=1S/C21H24ClN3/c22-18-5-3-4-16(12-18)13-23-19-8-10-25(11-9-19)15-17-14-24-21-7-2-1-6-20(17)21/h1-7,12,14,19,23-24H,8-11,13,15H2 | Definition date: | 2019-08-10 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-[(3-chlorophenyl)methyl]-1-(1~{H}-indol-3-ylmethyl)piperidin-4-amine |
|
 | LHK | Name: | (2~{S})-2-[[(2~{S})-1,4-bis(oxidanyl)-1,4-bis(oxidanylidene)butan-2-yl]sulfamoylamino]pentanedioic acid | Formula: | C9 H14 N2 O10 S | SMILES: | OC(=O)CC[CH](N[S](=O)(=O)N[CH](CC(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C9H14N2O10S/c12-6(13)2-1-4(8(16)17)10-22(20,21)11-5(9(18)19)3-7(14)15/h4-5,10-11H,1-3H2,(H,12,13)(H,14,15)(H,16,17)(H,18,19)/t4-,5-/m0/s1 | Definition date: | 2019-08-15 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | (2~{S})-2-[[(2~{S})-1,4-bis(oxidanyl)-1,4-bis(oxidanylidene)butan-2-yl]sulfamoylamino]pentanedioic acid |
|
 | M9Q | Name: | ethyl (~{Z})-3-[1-[(~{E},1~{R},4~{R})-4-[(1~{R},3~{a}~{S},4~{E},7~{a}~{R})-7~{a}-methyl-4-[(2~{Z})-2-[(3~{S},5~{R})-2-methylidene-3,5-bis(oxidanyl)cyclohexylidene]ethylidene]-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-1-yl]-1-oxidanyl-pent-2-enyl]cyclopropyl]prop-2-enoate | Formula: | C32 H46 O5 | SMILES: | CCOC(=O)C=CC1(CC1)[CH](O)C=C[CH](C)[CH]2CC[CH]3C(CCC[C]23C)=CC=C4C[CH](O)C[CH](O)C4=C | InChi: | InChI=1S/C32H46O5/c1-5-37-30(36)14-16-32(17-18-32)29(35)13-8-21(2)26-11-12-27-23(7-6-15-31(26,27)4)9-10-24-19-25(33)20-28(34)22(24)3/h8-10,13-14,16,21,25-29,33-35H,3,5-7,11-12,15,17-20H2,1-2,4H3/b13-8+,16-14-,23-9+,24-10-/t21-,25-,26-,27+,28+,29-,31-/m1/s1 | Definition date: | 2019-10-09 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ethyl (~{Z})-3-[1-[(~{E},1~{R},4~{R})-4-[(1~{R},3~{a}~{S},4~{E},7~{a}~{R})-7~{a}-methyl-4-[(2~{Z})-2-[(3~{S},5~{R})-2-methylidene-3,5-bis(oxidanyl)cyclohexylidene]ethylidene]-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-1-yl]-1-oxidanyl-pent-2-enyl]cyclopropyl]prop-2-enoate |
|
 | V9G | Name: | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-(2'-O-METHYL)-ADENOSINE | Formula: | C22 H32 N10 O17 P3 | SMILES: | CO[CH]1[CH](O)[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(=O)OC[CH]2O[CH]([CH](O)[CH]2O)[n]3cn(C)c4C(=O)NC(=Nc34)N)O[CH]1n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C22H32N10O17P3/c1-30-7-32(18-11(30)19(36)29-22(24)28-18)20-14(35)12(33)8(46-20)3-44-50(37,38)48-52(41,42)49-51(39,40)45-4-9-13(34)15(43-2)21(47-9)31-6-27-10-16(23)25-5-26-17(10)31/h5-9,12-15,20-21,33-35H,3-4H2,1-2H3,(H,37,38)(H,39,40)(H,41,42)(H2,23,25,26)(H3,24,28,29,36)/t8-,9-,12-,13-,14-,15-,20-,21-/m1/s1 | Definition date: | 2020-07-21 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | [[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-methoxy-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-7-methyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate |
|
 | VJ1 | Name: | 2-deoxy-3-O-[(1R,3R)-1,3-dihydroxytetradecyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-alpha-D-glucopyranose | Formula: | C34 H68 N O12 P | SMILES: | C(=O)(CC(CCCCCCCCCCC)O)NC1C(OP(O)(O)=O)OC(C(C1OC(CC(CCCCCCCCCCC)O)O)O)CO | InChi: | InChI=1S/C34H68NO12P/c1-3-5-7-9-11-13-15-17-19-21-26(37)23-29(39)35-31-33(32(41)28(25-36)45-34(31)47-48(42,43)44)46-30(40)24-27(38)22-20-18-16-14-12-10-8-6-4-2/h26-28,30-34,36-38,40-41H,3-25H2,1-2H3,(H,35,39)(H2,42,43,44)/t26-,27-,28-,30-,31-,32-,33-,34-/m1/s1 | Definition date: | 2020-08-13 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 2-deoxy-3-O-[(1R,3R)-1,3-dihydroxytetradecyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-alpha-D-glucopyranose |
|
 | VJ4 | Name: | 2-deoxy-2-{[(1S,3R)-1-hydroxy-3-(pentanoyloxy)undecyl]amino}-4-O-phosphono-alpha-D-glucopyranose | Formula: | C22 H44 N O11 P | SMILES: | N(C(CC(OC(=O)CCCC)CCCCCCCC)O)C1C(OC(C(OP(O)(=O)O)C1O)CO)O | InChi: | InChI=1S/C22H44NO11P/c1-3-5-7-8-9-10-11-15(32-18(26)12-6-4-2)13-17(25)23-19-20(27)21(34-35(29,30)31)16(14-24)33-22(19)28/h15-17,19-25,27-28H,3-14H2,1-2H3,(H2,29,30,31)/t15-,16-,17+,19-,20-,21-,22-/m1/s1 | Definition date: | 2020-08-13 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 2-deoxy-2-{[(1S,3R)-1-hydroxy-3-(pentanoyloxy)undecyl]amino}-4-O-phosphono-beta-D-glucopyranose |
|
 | T6S | Name: | alpha-D-glucopyranosyl 6-O-sulfo-alpha-D-glucopyranoside | Formula: | C12 H22 O14 S | SMILES: | C1(C(O)C(O)C(C(O1)OC2C(O)C(O)C(C(O2)CO)O)O)COS(O)(=O)=O | InChi: | InChI=1S/C12H22O14S/c13-1-3-5(14)7(16)9(18)11(24-3)26-12-10(19)8(17)6(15)4(25-12)2-23-27(20,21)22/h3-19H,1-2H2,(H,20,21,22)/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-/m1/s1 | Definition date: | 2018-08-07 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | alpha-D-glucopyranosyl 6-O-sulfo-alpha-D-glucopyranoside |
|
 | E4U | Name: | [(1~{R})-1-[[(2~{S})-2-[[2,5-bis(chloranyl)phenyl]carbonylamino]-3-(1~{H}-indol-3-yl)propanoyl]amino]-3-methyl-butyl]boronic acid | Formula: | C23 H26 B Cl2 N3 O4 | SMILES: | CC(C)C[CH](NC(=O)[CH](Cc1c[nH]c2ccccc12)NC(=O)c3cc(Cl)ccc3Cl)B(O)O | InChi: | InChI=1S/C23H26BCl2N3O4/c1-13(2)9-21(24(32)33)29-23(31)20(10-14-12-27-19-6-4-3-5-16(14)19)28-22(30)17-11-15(25)7-8-18(17)26/h3-8,11-13,20-21,27,32-33H,9-10H2,1-2H3,(H,28,30)(H,29,31)/t20-,21-/m0/s1 | Definition date: | 2019-10-16 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | [(1~{R})-1-[[(2~{S})-2-[[2,5-bis(chloranyl)phenyl]carbonylamino]-3-(1~{H}-indol-3-yl)propanoyl]amino]-3-methyl-butyl]boronic acid |
|
 | E5Z | Name: | ~{N}-[3-[(~{E})-2-(1~{H}-imidazol-5-yl)ethylideneamino]-3-oxidanylidene-propyl]-4-sulfamoyl-benzamide | Formula: | C15 H17 N5 O4 S | SMILES: | N[S](=O)(=O)c1ccc(cc1)C(=O)NCCC(=O)N=CCc2[nH]cnc2 | InChi: | InChI=1S/C15H17N5O4S/c16-25(23,24)13-3-1-11(2-4-13)15(22)19-8-6-14(21)18-7-5-12-9-17-10-20-12/h1-4,7,9-10H,5-6,8H2,(H,17,20)(H,19,22)(H2,16,23,24)/b18-7+ | Definition date: | 2018-02-20 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-[3-[(~{E})-2-(1~{H}-imidazol-5-yl)ethylideneamino]-3-oxidanylidene-propyl]-4-sulfamoyl-benzamide |
|
 | E68 | Name: | ~{N}-[2-[2-(1~{H}-imidazol-4-yl)ethylamino]-2-oxidanylidene-ethyl]-4-sulfamoyl-benzamide | Formula: | C14 H17 N5 O4 S | SMILES: | N[S](=O)(=O)c1ccc(cc1)C(=O)NCC(=O)NCCc2c[nH]cn2 | InChi: | InChI=1S/C14H17N5O4S/c15-24(22,23)12-3-1-10(2-4-12)14(21)18-8-13(20)17-6-5-11-7-16-9-19-11/h1-4,7,9H,5-6,8H2,(H,16,19)(H,17,20)(H,18,21)(H2,15,22,23) | Definition date: | 2018-02-20 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-[2-[2-(1~{H}-imidazol-4-yl)ethylamino]-2-oxidanylidene-ethyl]-4-sulfamoyl-benzamide |
|
 | E6B | Name: | ~{N}-[2-(1~{H}-imidazol-4-yl)ethyl]-4-sulfamoyl-benzamide | Formula: | C12 H14 N4 O3 S | SMILES: | N[S](=O)(=O)c1ccc(cc1)C(=O)NCCc2c[nH]cn2 | InChi: | InChI=1S/C12H14N4O3S/c13-20(18,19)11-3-1-9(2-4-11)12(17)15-6-5-10-7-14-8-16-10/h1-4,7-8H,5-6H2,(H,14,16)(H,15,17)(H2,13,18,19) | Definition date: | 2018-02-20 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | ~{N}-[2-(1~{H}-imidazol-4-yl)ethyl]-4-sulfamoyl-benzamide |
|
 | F4U | Name: | 2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-5-oxidanyl-isoindole-1,3-dione | Formula: | C13 H10 N2 O5 | SMILES: | Oc1ccc2C(=O)N([CH]3CCC(=O)NC3=O)C(=O)c2c1 | InChi: | InChI=1S/C13H10N2O5/c16-6-1-2-7-8(5-6)13(20)15(12(7)19)9-3-4-10(17)14-11(9)18/h1-2,5,9,16H,3-4H2,(H,14,17,18)/t9-/m0/s1 | Definition date: | 2020-03-26 | Last modified: | 2020-08-21 | Release date: | 2020-08-26 | Identifier: | 2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-5-oxidanyl-isoindole-1,3-dione |
|